Schwaiger, Rebecca
Maurus, Isabel
Lembeck, Moritz
Papazova, Irina
Greska, David
Muenz, Susanne
Sykorova, Eliska
Thieme, Cristina E.
Vogel, Bob O.
Mohnke, Sebastian
Huppertz, Charlotte
Roeh, Astrid
Keller-Varady, Katriona
Malchow, Berend
Walter, Henrik
Wolfarth, Bernd
Wölwer, Wolfgang
Henkel, Karsten
Hirjak, Dusan
Schmitt, Andrea
Hasan, Alkomiet
Meyer-Lindenberg, Andreas
Falkai, Peter
Roell, Lukas http://orcid.org/0000-0002-0284-2290
Funding for this research was provided by:
Bundesministerium für Bildung und Forschung (01EE1407E, 01EE2303A, 01EE2303F, 01EE2303C)
Studienstiftung des Deutschen Volkes
Universitätsklinik München
Article History
Received: 4 October 2023
Accepted: 24 February 2024
First Online: 29 March 2024
Declarations
:
: AS was an honorary speaker for TAD Pharma and Roche and a member of Roche advisory boards. AH is an editor of the German (DGPPN) schizophrenia treatment guidelines and first author of the WFSBP schizophrenia treatment guidelines; he has been on the advisory boards of and has received speaker fees from Janssen-Cilag, Lundbeck, Recordati, Rovi, and Otsuka. PF is a co-editor of the German (DGPPN) schizophrenia treatment guidelines and a co-author of the WFSBP schizophrenia treatment guidelines; he is on the advisory boards and receives speaker fees from Janssen, Lundbeck, Otsuka, Servier, and Richter. AML has disclosed receiving consultant fees and speaker fees from multiple organizations and institutions: Boehringer Ingelheim, Elsevier, Brainsway, Lundbeck Int. Neuroscience Foundation, Lundbeck A/S, Sumitomo Dainippon Pharma Co., Academic Medical Center of the University of Amsterdam, Synapsis Foundation-Alzheimer Research Switzerland, IBS Center for Synaptic Brain Dysfunction, Blueprint Partnership, University of Cambridge, Dt. Zentrum für Neurodegenerative Erkrankungen, Zürich University, Brain Mind Institute, L.E.K. Consulting, ICARE Schizophrenia, Science Advances, Foundation FondaMental, v Behring Röntgen Stiftung, The Wolfson Foundation, and Sage Therapeutics; in addition, he has received speaker fees from Lundbeck International Foundation, Paul Martini-Stiftung, Lilly Deutschland, Atheneum, Fama Public Relations, Institut d'investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Janssen-Cilag, Hertie Stiftung, Bodelschwingh-Klinik, Pfizer, Atheneum, University of Freiburg, Schizophrenia Academy, Hong Kong Society of Biological Psychiatry, Fama Public Relations, Spanish Society of Psychiatry, Italian Society of Biological Psychiatry, Reunions I Ciencia S.L. and Brain Center Rudolf Magnus UMC Utrecht. In addition, AML has received grants and awards, including the Prix Roger de Spoelberch grant and the CINP Lilly Neuroscience Clinical Research Award 2016. RS, IM, ML, IP, DG, SM, ES, CET, BOV, SM, CH, AR, KKV, BM, HW, BW, WW, KH, DH and LR report no conflicts of interest.